Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 4003

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Journal Article

Re: the promotion of nicergoline
1989 May;


Farmitalia Carlo Erba responded to an earlier MaLAM letter about the use of nicergoline in senile dementia, stroke and Parkinson’s disease but MaLAM still has concerns about the drug’s effectiveness.

*analysis/Farmitalia Carlo Erba/nicergoline/ neurologic drugs/MaLAM/Medical Lobby for Appropriate Marketing/ quality of information/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend